Human Genetics Society of Australasia (HGSA) 44th Annual Scientific Meeting

Illumina is a global leader in genomics – an industry at the intersection of biology and technology. Our mission is to improve human health by unlocking the power of the genome. Through innovation and collaboration, we are enabling genomic breakthroughs and helping simplify the patient diagnostic odyssey.

We dream big. We strive to make solutions increasingly simple, more accessible and always reliable. As a result, discoveries that were unimaginable even a few years ago are now becoming routine – and are making their way into patient treatment.

What causes a cancer cell to mutate? What is the origin of a puzzling disease? Is it possible to prevent the next outbreak? Or safeguard the world’s food supply? These are just a few of the challenges that inspire us to push the boundaries of our imagination.

Industry Workshop:

Singapore National Precision Medicine Strategy – A 10-year Roadmap
Tuesday 17^th August 2021
11:35 am - 12:35 pm (Adelaide time)

Prof. Patrick Tan
Executive Director,
Precision Health Research Singapore (PRECISE)
www.npm.sg

Singapore’s National Precision Medicine (NPM) program, a key focus of the national Research, Innovation and Enterprise (RIE) 2025 plan, is a 10-year strategic whole-of-government effort to transform healthcare in Singapore.

Launched in 2017, Singapore’s NPM strategy aims to enhance and accelerate biomedical research, health outcomes and economic growth. Precision Health Research, Singapore (PRECISE), established in 2021 is the central entity tasked to co-ordinate and implement Phase II of Singapore’s NPM strategy.

“As a sector leader, PRECISE will spearhead public-private partnerships to drive growth and propel the biomedical technology sector to the next level. Through NPM, we hope to contribute to Singaporeans living healthier lives as well as its eventual impact across other Asian countries.”